BRCA1 and cholangiocarcinoma: However, whether olaparib could enhance the radiosensitivity of CCA is not clear, so we aimed to detect BRCA1/2 mutations in CCA cells and evaluate the influence of olaparib doses with different radiation doses on the growth of CCA cells.